Nkcfo LLC Moderna, Inc. Transaction History

Nkcfo LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	SELL	$117.13 - $176.59 $175,695 - $264,885	-1,500 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$126.46 - $235.05 $63,230 - $117,525	-500 Reduced 25.0%	1,500 $258,000
Q4 2021 Jan 27, 2022	BUY	$225.82 - $368.51 $451,640 - $737,020	2,000 New	2,000 $508,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Nkcfo LLC, based on Form 13F filings with the SEC.

Stay updated on Nkcfo LLC with notifications on news.